Berelowitz Michael
Insider CIK 1493383 · ORMP.OB Director · REPH Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SCTL Societal CDMO, Inc. | A Award deriv | 2022-05-18 | 2022-05-20 | 118,182 | — | $0 | 118,182 | SEC↗ |
| SCTL Societal CDMO, Inc. | A Award | 2022-05-18 | 2022-05-20 | 87,500 | — | $0 | 164,046 | SEC↗ |
| REPH Recro Pharma, Inc. | A Award deriv | 2021-04-20 | 2021-04-22 | 38,012 | — | $0 | 38,012 | SEC↗ |
| REPH Recro Pharma, Inc. | A Award deriv | 2021-04-20 | 2021-05-17 | 38,012 | — | $0 | 38,012 | SEC↗ |
| REPH Recro Pharma, Inc. | A Award | 2021-04-20 | 2021-04-22 | 26,923 | — | $0 | 76,546 | SEC↗ |
| REPH Recro Pharma, Inc. | A Award deriv | 2020-05-07 | 2020-05-11 | 12,405 | — | $0 | 12,405 | SEC↗ |
| REPH Recro Pharma, Inc. | A Award | 2020-05-07 | 2020-05-11 | 8,363 | — | $0 | 49,623 | SEC↗ |
| REPH Recro Pharma, Inc. | A Award | 2019-12-05 | 2019-12-09 | 13,848 | — | $0 | 41,260 | SEC↗ |
| REPH Recro Pharma, Inc. | A Award deriv | 2019-05-09 | 2019-05-10 | 10,888 | — | $0 | 10,888 | SEC↗ |
| REPH Recro Pharma, Inc. | A Award | 2019-05-09 | 2019-05-10 | 7,955 | — | $0 | 27,412 | SEC↗ |
| REPH Recro Pharma, Inc. | M Exercise deriv | 2018-05-12 | 2018-05-14 | 13,274 | — | $0 | 0 | SEC↗ |
| REPH Recro Pharma, Inc. | M Exercise | 2018-05-12 | 2018-05-14 | 13,274 | — | $0 | 19,457 | SEC↗ |
| REPH Recro Pharma, Inc. | A Award deriv | 2018-05-04 | 2018-05-08 | 5,742 | — | $0 | 5,742 | SEC↗ |
| REPH Recro Pharma, Inc. | A Award deriv | 2018-05-04 | 2018-05-10 | 8,965 | — | $0 | 8,965 | SEC↗ |
| REPH Recro Pharma, Inc. | A Award | 2018-05-04 | 2018-05-08 | 6,183 | — | $0 | 6,183 | SEC↗ |
| REPH Recro Pharma, Inc. | M Exercise deriv | 2018-03-09 | 2018-03-13 | 7,500 | — | $0 | 14,500 | SEC↗ |
| REPH Recro Pharma, Inc. | M Exercise | 2018-03-09 | 2018-03-13 | 7,500 | $2.47 | $18.5K | 7,500 | SEC↗ |
| REPH Recro Pharma, Inc. | S Sale | 2018-03-09 | 2018-03-13 | 7,500 | $10.45 | $78.4K | 0 | SEC↗ |
| REPH Recro Pharma, Inc. | A Award deriv | 2017-05-12 | 2017-05-16 | 13,274 | — | $0 | 13,274 | SEC↗ |
| REPH Recro Pharma, Inc. | A Award deriv | 2015-12-16 | 2015-12-18 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ORMP ORAMED PHARMACEUTICALS INC | S Sale | 2015-12-09 | 2015-12-10 | 700 | $9.44 | $6.6K | 22,896 | SEC↗ |
| ORMP ORAMED PHARMACEUTICALS INC | S Sale | 2015-12-08 | 2015-12-09 | 761 | $8.70 | $6.6K | 23,596 | SEC↗ |
| ORMP ORAMED PHARMACEUTICALS INC | S Sale | 2015-12-07 | 2015-12-09 | 539 | $8.70 | $4.7K | 24,357 | SEC↗ |
| ORMP ORAMED PHARMACEUTICALS INC | A Award | 2015-02-23 | 2015-02-25 | 22,178 | — | $0 | 24,896 | SEC↗ |
| REPH Recro Pharma, Inc. | A Award deriv | 2014-12-17 | 2014-12-19 | 22,000 | — | $0 | 22,000 | SEC↗ |
| ORMP ORAMED PHARMACEUTICALS INC | A Award | 2014-11-13 | 2014-11-17 | 2,718 | — | $0 | 2,718 | SEC↗ |
| ORMP ORAMED PHARMACEUTICALS INC | A Award deriv | 2014-04-09 | 2014-04-11 | 13,094 | — | $0 | 13,094 | SEC↗ |
| ORMP ORAMED PHARMACEUTICALS INC | M Exercise deriv | 2014-03-31 | 2014-04-02 | 3,334 | — | $0 | 0 | SEC↗ |
| ORMP ORAMED PHARMACEUTICALS INC | M Exercise deriv | 2014-03-31 | 2014-04-02 | 6,100 | — | $0 | 18,900 | SEC↗ |
| ORMP ORAMED PHARMACEUTICALS INC | S Sale | 2014-03-31 | 2014-04-02 | 9,434 | $10.50 | $99.1K | 0 | SEC↗ |
| ORMP ORAMED PHARMACEUTICALS INC | M Exercise | 2014-03-31 | 2014-04-02 | 3,334 | $4.08 | $13.6K | 3,334 | SEC↗ |
| ORMP ORAMED PHARMACEUTICALS INC | M Exercise | 2014-03-31 | 2014-04-02 | 6,100 | $5.76 | $35.1K | 9,434 | SEC↗ |
| REPH Recro Pharma, Inc. | A Award deriv | 2014-03-12 | 2014-03-13 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ORMP.OB ORAMED PHARMACEUTICALS INC | A Award deriv | 2012-08-08 | 2012-08-09 | 40,000 | — | $0 | 340,000 | SEC↗ |